U-Chart Analysis:Kringle Pharma,Inc.:4884

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Kringle Pharma,Inc. 4884 Medicals 東証グロース September 1, 2000 2020.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Kringle Pharma,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Kringle Pharma,Inc. Balance Sheet 2023年9月期 Kringle Pharma,Inc. Balance Sheet 2022年9月期 Kringle Pharma,Inc. Balance Sheet 2021年9月期 Kringle Pharma,Inc. Balance Sheet 2020年9月期 Kringle Pharma,Inc. Balance Sheet 2019年9月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date September 30, 2023 September 30, 2022 September 30, 2021 September 30, 2020 September 30, 2019
Cash and Cash Equivalents 2,136 2,756 2,138 2,103 166
Other Current AssetsHelp 481 451 497 247 84
Tangible Fixed AssetsHelp 0 0 0 0 0
Intangible Fixed AssetHelp 0 0 0 0 0
Investments and OthersHelp 1 1 1 1 1
Total AssetsHelp 2,619 3,209 2,636 2,350 252
Total Current LiabilitiesHelp 597 420 129 162 35
Total Long-term LiabilitiesHelp 0 0 0 0 0
Shareholder's EquityHelp 2,022 2,789 2,506 2,189 216
Total LiabilitiesHelp 2,619 3,209 2,636 2,350 252

Kringle Pharma,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Kringle Pharma,Inc. Profit and Loss Account 2023年9月期 Kringle Pharma,Inc. Profit and Loss Account 2022年9月期 Kringle Pharma,Inc. Profit and Loss Account 2021年9月期 Kringle Pharma,Inc. Profit and Loss Account 2020年9月期 Kringle Pharma,Inc. Profit and Loss Account 2019年9月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date September 30, 2023 September 30, 2022 September 30, 2021 September 30, 2020 September 30, 2019
Amount of Sales 69 392 290 468 0
Total Sales 69 392 290 468 0
Cost of SalesHelp - 88 72 0 0
Other Costs and RevenueHelp 923 635 519 585 302
Total CostsHelp 923 724 591 585 302
Net RevenueHelp - 303 218 468 0
Earnings Before TaxHelp -853 -330 -300 -116 -302
Net IncomeHelp -854 -332 -301 -118 -302
Net Income -854 -332 -301 -118 -302

Kringle Pharma,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Kringle Pharma,Inc. Cash Flow Statement 2023年9月期 Kringle Pharma,Inc. Cash Flow Statement 2022年9月期 Kringle Pharma,Inc. Cash Flow Statement 2021年9月期 Kringle Pharma,Inc. Cash Flow Statement 2020年9月期 Kringle Pharma,Inc. Cash Flow Statement 2019年9月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date September 30, 2023 September 30, 2022 September 30, 2021 September 30, 2020 September 30, 2019
Operating Cash Flow(OFC)Help -689 16 -561 -146 -339
Investing Cash Flow(ICF)Help - -121 -254 - -254
Financing Cash FlowHelp 69 603 596 596 2,083
Exchange Difference of Cash and Cash EquivalentsHelp - -134 254 - -1,828
Net Increase and Decrease in Cash and Cash Equivalentsn -741 365 35 1,936 -339

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Kringle Pharma,Inc.

Company where related level is highHelp

D.Western Therapeutics Institute, Inc.
Toyama Chemical Co.,Ltd.
StemRIM Inc.
MUROMACHI CHEMICALS INC.
KISSEI PHARMACEUTICAL CO.,LTD.
ASKA Pharmaceutical Holdings Co., Ltd.
Mochida Pharmaceutical Co.,Ltd.
Kyowa Kirin Co.,Ltd.
Shionogi & Co.,Ltd.
Fuso Pharmaceutical Industries, Ltd.